Variant GADL1 and Response to Lithium Therapy in Bipolar I Disorder
New England Journal of Medicine2013Vol. 370(2), pp. 119–128
Citations Over TimeTop 1% of 2013 papers
Chien-Hsiun Chen, Chau‐Shoun Lee, Ming‐Ta Michael Lee, Wen‐Chen Ouyang, Chiao-Chicy Chen, Mian‐Yoon Chong, Jer‐Yuarn Wu, Happy Kuy‐Lok Tan, Yi‐Ching Lee, Liang-Jen Chuo, Nan‐Ying Chiu, Hin‐Yeung Tsang, T J Chang, For‐Wey Lung, Chen‐Huan Chiu, Cheng‐Ho Chang, Ying-Sheue Chen, Yuh‐Ming Hou, Cheng‐Chung Chen, Te‐Jen Lai, Chun‐Liang Tung, Chung-Ying Chen, Hsien‐Yuan Lane, Tung‐Ping Su, Jung Feng, Jin‐Jia Lin, Ching‐Jui Chang, Po‐Ren Teng, Chia-Yih Liu, Chih-Ken Chen, I‐Chao Liu, Jiahn‐Jyh Chen, Ti Lu, Chun-Chieh Fan, Ching-Kuan Wu, Chang-Fang Li, Kathy Hsiao-Tsz Wang, Lawrence Shih‐Hsin Wu, Hsin-Ling Peng, Chun-Ping Chang, Liang-Suei Lu, Yuan-Tsong Chen, Andrew T. A. Cheng
Abstract
Genetic variations in GADL1 are associated with the response to lithium maintenance treatment for bipolar I disorder in patients of Han Chinese descent. (Funded by Academia Sinica and others.).
Related Papers
- → CK levels in unmedicated bipolar patients(2007)19 cited
- → THE EFFECT OF LITHIUM IN DEPRESSIVE SUBTYPES(1978)2 cited
- → Risk of Treatment-Emergent Mania Increases After Antidepressant Use(2009)
- Lorazepam vs lithium carbonate in treatment of mania(1996)
- A case control study of quetiapine with lithium therapeutic mania(2007)